leisure time -WSS

leisure time

author：leisure time 2025-10-01 12:54:36 - browse：3936

An artist's rendering of the building — currently under construction along Boston's Fort Point Channel — where Eli Lilly plans to open its Institute for Genetic Medicine. Courtesy Alexandria Real Estate Equities Inc

Eli Lilly and Co., which transformed itself from a stodgy underperformer into one of the world’s hottest pharmaceutical companies, said this week that the genetic medicine research center it plans to open in Boston in August will eventually employ twice as many workers as originally estimated.

In February 2022, Lilly said that it would increase its modest Massachusetts workforce from 120 to 250 employees when it opened the $700 million Lilly Institute for Genetic Medicine along Fort Point Channel. The Indianapolis-based company said it would move 120 scientists from Kendall Square in Cambridge to the institute and add another 130.

But Daniel Skovronsky, Lilly’s chief scientific and medical officer, said in an interview that the 12-story, 334,000-square-foot laboratory and office building will ultimately accommodate 500 Lilly scientists and researchers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Why getting cancer drugs just got harder for rural patients

focus

WSS

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Why getting cancer drugs just got harder for rural patients

Congress gives doctors Medicare pay bump

Medicaid rebukes states for mistakenly disenrolling children

How to fix the rural physician shortage in the U.S.

hotspot

leisure time

focus

Jerome Adams on the need for new antivirals for Covid

How to address the problem of discarded donor organs

State Dept. review finds Biden bears some blame for Afghanistan failures

How generative AI is inspiring dreams of a health data revolution

Sports medicine is finally prioritizing gender equality

AstraZeneca loses challenge to Medicare drug price negotiation

Virginia high school admissions case could be legal follow

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Medical records are filled with copy

International team creates first chimeric human

knowledge

Snackable artificial intelligence, expert AI, and the pharma industry

NIH nominee Bertagnolli will get October confirmation hearing

NIH nominee Bertagnolli will get October confirmation hearing

Biotech companies concerned about China biosecurity crackdown

Humana sues Biden admin over Medicare Advantage audit rule

A Q&A with Aletha Maybank, AMA’s chief health equity officer

focus

entertainment

hotspot

focus